[{
 	"id": 11,
 	"name": "Gastrointestinal", 
	"question1": "Question GI contents", 
	"contents": "Testing GI contents 1", 
	"question2": "Question GI 2", 
	"contents2": "Testing GI contents 2", 	
	"question3": "Question GI 3", 
	"contents3": "Testing GI contents 3" 	
 }, {
 	"id": 12,
 	"name": "Cardiovascular",
	"question1": "Question Cardiovascular contents", 
	"contents": "Testing Cardiovascular contents 1", 
	"question2": "Question Cardiovascular 2", 
	"contents2": "Testing Cardiovascular contents 2", 	
	"question3": "Question Cardiovascular 3", 
	"contents3": "Testing Cardiovascular contents 3" 	
 }, 
{
 	"id": 13,
 	"name": "Cardiac Pacing",
	"question1": "Question Cardiovascular contents", 
	"contents": "<h2>Cardiac Pacing</h2><p>Surgeons put in Epicardium (ie, outside of heart - because they need to take off).&nbsp;</p><p><strong>Indications : </strong></p><ol><li>Weaning off of CPB (because during CPB cardioplegic , ie asystolic)&nbsp;<ul><li>can take time to get back heart rhythm</li><li>RV pacing wires - to take off bypass - temporary indication</li></ul></li><li>AV nodal dysfunction&nbsp;<ol><li>normally valve or open heart&nbsp;</li><li>AV (local to valves) fibrous skeleton - surrounding valves - aortic valve surgery in particular --&gt; PPM (2%)&nbsp;<ol><li>Direct physical damage&nbsp;</li><li>Oedema of AV node (may occur up to 72hrs after surgery)&nbsp;<ol><li>Epicardial pacing is a bridge to recovery</li></ol></li></ol></li></ol></li><li>Prevention or treatment of secondary bradycardias in high risk patients&nbsp;<ol><li>pre-existent AVN disease&nbsp;</li><li>surgeries with increased risk of bleeding/ischemia/surgical</li><li>patients with complex co-morbities&nbsp;</li><li>-&gt; Ventricular pacing system is required.&nbsp;</li></ol></li><li>Optimisation of post-operative cardiac output&nbsp;<ol><li>this requires use of an atrial pacing system (unless pt. has persistent AF) **arguably most important.&nbsp;</li></ol></li></ol><p>Ventricular pacing can be acutely life-saving&nbsp; -however if you have integretity of AV nodal conduction - then the patient can become hypotensive.&nbsp;</p><p>1st Letter: Pacing, 2nd letter: Sensing, 3rd Letter: Effect (from sensed)</p><p><strong>4 Outcomes of DDD Mode&nbsp;</strong></p><ol><li>Both leads inhibited/sensing only 'back up' normal sinus - no pacing spikes</li><li>Pacing atria/sensing ventricles = rhythm is 'atrially paced' same as AAI</li><li>Sensing atria/pacing ventricles = 'tracking the atrial rate' treating heart block ; same as VDD&nbsp;</li><li>Pacing both atria and ventricles 'AV sequential pacing' 2 pacing spikes</li></ol><p><strong>Pacing settings</strong></p><ul><li>Pacing capture - how much voltage required to pace<ul><li>capture threshold - at what point does the pacing not produce a QRS -&gt; then programme unit to x2-3 threshold&nbsp;</li><li>Normal impedence (200-1500 ohms) - so I = V/R(impedence) so increasing voltage can overcome higher impedence caused by poor wires/system</li><li>Low capture &lt;3V = good&nbsp;</li></ul></li><li>Sensing - sensing threshold is the amplitude of R wave&nbsp;<ul><li>so set VSense to be 1/3 of that so that it captures every R wave and therefore every asystole, but is higher than interference/artefact&nbsp;</li><li>High R wave is better (stronger) eg 6mV giving Vsense of 2mV&nbsp;</li><li>Having to set it lower would pick up interference.&nbsp;</li></ul></li></ul>",
	"question2": "Question 2", 
	"contents2": "Testing contents 2", 	
	"question3": "Question 3", 
	"contents3": "Testing contents 3" 	
 },
{"id": 20, "name": "Vasodilators", "question1": "GTN and Sodium Nitroprusside","contents": "<p>GLYCERYL TRINITRATE</p><p><strong>Chemical</strong>: Glyceryl trinitrate (GTN) is an organic nitrate</p><p><strong>Uses</strong>: GTN is used in the treatment and prophylaxis of angina, LV failure associated with myocardial infarction and following cardiac surgery.  It has alos been sued in the control of intra-operative blood pressure and for oesophageal spasm. </p><p><strong>Presentation</strong> : prepared in the following formulations: </p><ul><li>an aerosol spray delivering 400 micrograms per metered dose and tablets containing 300-600 micrograms, both used sublingually.</li><li>modified-release tablets containing 1-5mg for buccal admin are placed between the upper lip and gum and are used at a maximum dose of 5mg TDS while 2.6-10mg modified release tablets are to be swallowed and used at a maximum dose of 2.6-10mg</li><li>the transdermal patch prep release 5-15 mg/24hrs and should be re-sited at a different location on the chest.  </li><li>IV injection - contains 1-5mg/ml (we used 1mg/1ml in Cardiac in Infusion containing 25mg/25ml) and should be diluted to a 0.01% (100micrograms/ml) solution before administration by an infusion pump and is used at 10-200micrograms/min).  QA - also has a 10ml syringe with 100 micrograms/ml available. (check this)</li></ul><p><strong>(A)MOA</strong>:  GTN vasodilates the veins by the production of Nitric oxide.  This activates the <u>enzyme guanylate cyclase</u> leading to increased levels of Intracellular cyclic GMP.  <em>Although Ca2+ influx into vascular smooth muscle is inhibited, its uptake into smooth endoplasmic reticulum is enhanced so that cytoplasmic levels fall resulting in vasodilatation. **does cGMP inhibit Ca2+ influx**</em></p><p>Dose:  Onset:  R: S: E: T: </p><p><strong>Effects: </strong></p><p><strong>Cardiovascular:  </strong>GTN produces vasodilatation in the capacitance vessels, that is veins</p><p><br></p>", "question2": "contents of Question GI 2 ", "contents2": "null", "question3": "contents of Question GI 3 ", "contents3": "null" }, 
{"id": 100, "name": "Optics", "question1": "Question GI contents","contents": "<p>A probe is placed on the finger, toe, ear lobe or nose.&nbsp;</p><ul><li>Two<strong> light-emitting diodes</strong> produce beams at red and infrared frequencies (660 nm and 940 nm, respectively).&nbsp;</li><li>There is a <strong>photo detector</strong> on the other side.&nbsp;</li><li>The <strong>diodes flash at approximately 30 times per second</strong>.&nbsp;</li><li>The diodes are switched on in sequence, with a pause with both diodes off. (This allows compensation for ambient light.)</li><li>The microprocessor analyses the changes in light absorption during the arterial pulsatile flow and ignores the non-pulsatile component of the signal (which results from the tissues and venous blood).</li></ul><p>The oxygen saturation is estimated by measuring the transmission of light through the pulsatile tissue bed. This is based on the Beer-Lambert law:</p><p><strong>Beer-Lambert law : </strong>This is a combination of two laws describing absorption of monochromatic light by a transparent substance through which it passes:</p><p><strong>Beer's law: </strong>The Intensity of light received decreases exponentially as the concentration of the substance through which it travels increases.</p><p><br></p><p><img src=\"data:image/jpeg;base64,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\"></p>", "question2": "contents of Question GI 2 ", "contents2": "null", "question3": "contents of Question GI 3 ", "contents3": "null" }

]



